Musings re Silviu, page-2

A very thoughtful post antibody. The Professor should stay, no doubt about that. He is the brains behind the science and has done well to this point. But on a corporate level I think it's time to bring in some experience and hard-headed business acumen. This is a public company. And shareholders must be served and indeed recognised. The Nasdaq fiasco clearly underlines this need. We all want MSB to succeed and much of the criticism in here is driven by this desire, regardless of those that think we are all traders, shorters and questionable types. My personal outbursts are reflective of this - they are not an attempt to downgrade the company or indeed scare people off as I am still heavily invested.If we don't agitate for change who the hell will?